These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 21744112
1. Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. Nobili F, Arnaldi D, Campus C, Ferrara M, De Carli F, Brugnolo A, Dessi B, Girtler N, Morbelli S, Abruzzese G, Sambuceti G, Rodriguez G. Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2209-18. PubMed ID: 21744112 [Abstract] [Full Text] [Related]
2. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. Nobili F, Campus C, Arnaldi D, De Carli F, Cabassi G, Brugnolo A, Dessi B, Morbelli S, Sambuceti G, Abbruzzese G, Rodriguez G. Mov Disord; 2010 Jan 15; 25(1):35-43. PubMed ID: 20058228 [Abstract] [Full Text] [Related]
3. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study. Nobili F, Abbruzzese G, Morbelli S, Marchese R, Girtler N, Dessi B, Brugnolo A, Canepa C, Drosos GC, Sambuceti G, Rodriguez G. Mov Disord; 2009 Feb 15; 24(3):414-21. PubMed ID: 19235928 [Abstract] [Full Text] [Related]
4. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G. Clin Neurophysiol; 2005 Feb 15; 116(2):364-75. PubMed ID: 15661114 [Abstract] [Full Text] [Related]
5. What predicts cognitive decline in de novo Parkinson's disease? Arnaldi D, Campus C, Ferrara M, Famà F, Picco A, De Carli F, Accardo J, Brugnolo A, Sambuceti G, Morbelli S, Nobili F. Neurobiol Aging; 2012 Jun 15; 33(6):1127.e11-20. PubMed ID: 22226489 [Abstract] [Full Text] [Related]
6. SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease. Paschali A, Messinis L, Kargiotis O, Lakiotis V, Kefalopoulou Z, Constantoyannis C, Papathanasopoulos P, Vassilakos P. Eur J Nucl Med Mol Imaging; 2010 Jun 15; 37(6):1128-40. PubMed ID: 20145921 [Abstract] [Full Text] [Related]
7. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). Nobili F, Morbelli S, Arnaldi D, Ferrara M, Campus C, Brugnolo A, Mazzei D, Mehrdad N, Sambuceti G, Rodriguez G. J Neurol Sci; 2011 Nov 15; 310(1-2):31-5. PubMed ID: 21762928 [Abstract] [Full Text] [Related]
8. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders. Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC. Eur J Nucl Med Mol Imaging; 2019 Sep 15; 46(10):2065-2076. PubMed ID: 31273436 [Abstract] [Full Text] [Related]
9. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease. Siepel FJ, Brønnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Grüner R, Aarsland D. Mov Disord; 2014 Dec 15; 29(14):1802-8. PubMed ID: 25284687 [Abstract] [Full Text] [Related]
10. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests. Chang CC, Liu JS, Chang YY, Chang WN, Chen SS, Lee CH. Eur J Neurol; 2008 Jan 15; 15(1):61-5. PubMed ID: 18042240 [Abstract] [Full Text] [Related]
11. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease. Ham JH, Cha J, Lee JJ, Baek GM, Sunwoo MK, Hong JY, Shin NY, Sohn YH, Lee JM, Lee PH. Neuroimage; 2015 Oct 01; 119():296-304. PubMed ID: 26143204 [Abstract] [Full Text] [Related]
12. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination. Wakamori T, Agari T, Yasuhara T, Kameda M, Kondo A, Shinko A, Sasada S, Sasaki T, Furuta T, Date I. Parkinsonism Relat Disord; 2014 Apr 01; 20(4):415-20. PubMed ID: 24467818 [Abstract] [Full Text] [Related]
13. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease. Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH. Parkinsonism Relat Disord; 2018 Jun 01; 51():43-48. PubMed ID: 29526657 [Abstract] [Full Text] [Related]
14. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Melzer TR, Watts R, MacAskill MR, Pearson JF, Rüeger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ. Brain; 2011 Mar 01; 134(Pt 3):845-55. PubMed ID: 21310726 [Abstract] [Full Text] [Related]
15. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study. Pellecchia MT, Picillo M, Santangelo G, Longo K, Moccia M, Erro R, Amboni M, Vitale C, Vicidomini C, Salvatore M, Barone P, Pappatà S. Acta Neurol Scand; 2015 May 01; 131(5):275-81. PubMed ID: 25644029 [Abstract] [Full Text] [Related]
18. Brain perfusion alterations in depressed patients with Parkinson's disease. Kim YD, Jeong HS, Song IU, Chung YA, Namgung E, Kim YD. Ann Nucl Med; 2016 Dec 01; 30(10):731-737. PubMed ID: 27566684 [Abstract] [Full Text] [Related]